Abstract:Highlights • Delayed effects of acute radiation exposure induce intestinal senescence. • Nicotinamide riboside alleviates ionizing radiation-induced intestinal senescence. • Nicotinamide riboside mitigates oxidative damage in the intestinal crypts and restores the normal functionality of intestinal stem cells. • Nicotinamide riboside rebalances intestinal dysbiosis and metabolic disruption. • Nicotinamide riboside suppresses the activation of the mTORC1 pathway induced by ionizing radiation. Introduction The intestine, frequently subjected to pelvic or abdominal radiotherapy, is particularly vulnerable to delayed effects of acute radiation exposure (DEARE) owing to its high radiation sensitivity. Radiation-induced intestinal senescence, a result of DEARE, profoundly affects the well-being and quality of life of radiotherapy patients. However, targeted pharmaceutical interventions for radiation-induced senescence are currently scarce. Our findings showcase that nicotinamide riboside(NR) effectively alleviates radiation-induced intestinal senescence, offering crucial implications for utilizing NR as a pharmacological agent to combat intestinal DEARE. Objectives The aim of this study was to investigate the ability of NR to reduce radiation induced intestinal senescence and explore its related mechanisms. Methods Male C57BL/6J mice were randomly divided into CON, IR, and IR + NR groups. The mice in the IR and IR + NR groups were subjected to a 6.0 Gy γ-ray total body exposure. After 8 weeks, the mice in the IR + NR group received NR via gavage at a dose of 400 mg/kg/d for 21 days. Then the mice were used for sample collection. Results Our results demonstrate that NR can significantly mitigate radiation-induced intestinal senescence. Furthermore, our findings indicate that NR can mitigate oxidative damage, restore the normal function of intestinal stem cells, regulate the disruption of the intestinal symbiotic ecosystem and address metabolic abnormalities. In addition, the underlying mechanisms involve the activation of SIRT6, SIRT7 and the inhibition of the mTORC1 pathway by NR. Conclusion In conclusion, our results reveal the substantial inhibitory effects of NR on radiation-induced intestinal senescence. These findings offer valuable insights into the potential therapeutic use of NR as a pharmacological agent for alleviating intestinal DEARE. Graphical abstract NR treats IR-induced senescence by suppressing oxidative stress, attenuating DNA damage to restore ISC function, and alleviating metabolic dysregulation through inhibiting mTORC1 pathway activation. Download: Download high-res image (121KB) Download: Download full-size image

Nicotinamide riboside alleviates cisplatin-induced peripheral neuropathy via SIRT2 activation

Nicotinamide N -methyltransferase enhances chemoresistance in breast cancer through SIRT1 protein stabilization

Nicotinamide Mononucleotide Prevents Cisplatin-Induced Cognitive Impairments

Pharmacological Inhibition of NADPH Oxidase Protects Against Cisplatin Induced Nephrotoxicity in Mice by Two Step Mechanism

Nicotinamide riboside activates SIRT3 to prevent paclitaxel-induced peripheral neuropathy

Depletion of senescent-like neuronal cells alleviates cisplatin-induced peripheral neuropathy in mice

Modulation of NAD+ biosynthesis activates SIRT1 and resists cisplatin-induced ototoxicity

Nicotinamide Adenine Dinucleotide Precursor Suppresses Hepatocellular Cancer Progression in Mice

The Role of NMNAT2/SARM1 in Neuropathy Development

PEGylated nanoliposomal cisplatin ameliorates chemotherapy-induced peripheral neuropathy

Nicotinamide ribose ameliorates myocardial ischemia/reperfusion injury by regulating autophagy and regulating oxidative stress

Nicotinamide Riboside Regulates Chemotaxis to Decrease Inflammation and Ameliorate Functional Recovery Following Spinal Cord Injury in Mice

Cisplatin-induced peripheral neuropathy is associated with neuronal senescence-like response

Nicotinamide Riboside Protects Against Liver Fibrosis Induced by CCl4 Via Regulating the Acetylation of Smads Signaling Pathway.

Nicotinamide riboside alleviates ionizing radiation-induced intestinal senescence by alleviating oxidative damage and regulating intestinal metabolism

Nicorandil attenuates cisplatin-induced acute kidney injury in rats via activation of PI3K/AKT/mTOR signaling cascade and inhibition of autophagy

Nicotinamide riboside promotes autolysosome clearance in preventing doxorubicin-induced cardiotoxicity.

Nrf2 Inhibits Oxaliplatin-Induced Peripheral Neuropathy Via Protection of Mitochondrial Function.

Nicotinamide riboside attenuates myocardial ischemia-reperfusion injury via regulating SIRT3/SOD2 signaling pathway

Neuroprotective Effects of Trimetazidine against Cisplatin‐Induced Peripheral Neuropathy: Involvement of AMPK‐Mediated PI3K/mTOR, Nrf2, and NF‐ κ B Signaling Axes

Combined effect of naringin and adipose tissue-derived mesenchymal stem cell on cisplatin nephrotoxicity through Sirtuin1/Nrf-2/HO-1 signaling pathway: a promising nephroprotective candidate